Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Mar. 27, 2016	Mar. 29, 2015	Mar. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 5,340,500	$ 8,634,300	$ 16,249,100
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	4,730,000	4,583,600	4,865,000
Gain on sale of property and equipment		(3,000)	(29,500)
Non-cash stock-based compensation expense	729,000	1,161,300	2,087,100
Deferred income taxes and other	(47,687)	1,347,200	(1,042,400)
Change in trade accounts receivable	1,256,400	7,923,600	14,681,900
Change in product inventory	18,459,700	(10,407,900)	(1,042,100)
Change in prepaid expenses and other current assets	4,951,800	(8,532,300)	1,145,700
Change in trade accounts payable	(9,818,200)	1,047,300	(14,452,400)
Change in payroll, benefits and taxes	(604,000)	(2,138,200)	(4,008,400)
Change in income and sales tax liabilities	(375,600)	(645,300)	(53,000)
Change in accrued expenses and other current liabilities	(4,480,800)	8,109,200	264,400
Net cash provided by operating activities	20,141,113	11,079,800	18,665,400
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(3,513,813)	(2,950,600)	(4,745,000)
Proceeds from sale of property and equipment		3,000	29,500
Net cash used in investing activities	(3,513,813)	(2,947,600)	(4,715,500)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments on long-term debt	(250,600)	(250,200)	(249,600)
Proceeds from issuance of stock	153,700	195,900	213,300
Cash dividends paid	(6,615,700)	(6,628,800)	(6,086,100)
Purchases of treasury stock and repurchases of common stock from employees and directors for minimum tax withholdings	(937,300)	(6,223,300)	(1,646,300)
Excess tax benefit from stock-based compensation	381,400	830,300	818,700
Net cash used in financing activities	(7,268,500)	(12,076,100)	(6,950,000)
Net increase (decrease) in cash and cash equivalents	9,358,800	(3,943,900)	6,999,900
CASH AND CASH EQUIVALENTS, beginning of period	7,524,000	11,467,900	4,468,000
CASH AND CASH EQUIVALENTS, end of period	$ 16,882,800	$ 7,524,000	$ 11,467,900